ABBOTT LABORATORIES — Director's Dealing 2009

Oct 22, 2009

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ABBOTT LABORATORIES (ABT)
CIK: 0000001800
Period of Report: 2009-10-20

Reporting Person: Warmuth Michael J (Senior Vice President)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2009-10-20	Common shares without par value	M	7392	$41.0317	Acquired	76847	Direct
2009-10-20	Common shares without par value	F	6274	$52.23	Disposed	70573	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2009-10-20	Option (right to buy)	$41.0317	M	7392	Disposed	2014-02-19	Common shares (7392)	Direct
2009-10-20	Option (right to buy)	$52.23	A	6274	Acquired	2014-02-19	Common shares (6274)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common shares without par value	72	Indirect
Common shares without par value	24	Indirect

Footnotes

F1: The reporting person disclaims beneficial ownership of all securities held by his spouse.

F2: Balance in the Abbott Laboratories Stock Retirement Trust as of October 21, 2009.

F3: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16 under Rule 16b-3.

F4: Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16 under Rule 16b-3.